ATE224446T1 - Menschlicher rezeptor für das follikel- stimulierendes hormon. - Google Patents
Menschlicher rezeptor für das follikel- stimulierendes hormon.Info
- Publication number
- ATE224446T1 ATE224446T1 AT92904833T AT92904833T ATE224446T1 AT E224446 T1 ATE224446 T1 AT E224446T1 AT 92904833 T AT92904833 T AT 92904833T AT 92904833 T AT92904833 T AT 92904833T AT E224446 T1 ATE224446 T1 AT E224446T1
- Authority
- AT
- Austria
- Prior art keywords
- receptor
- mutant
- fragment
- fsh
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67008591A | 1991-03-15 | 1991-03-15 | |
PCT/US1992/000122 WO1992016620A1 (en) | 1991-03-15 | 1992-01-02 | Human follicle stimulating hormone receptor |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE224446T1 true ATE224446T1 (de) | 2002-10-15 |
Family
ID=24688922
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92904833T ATE224446T1 (de) | 1991-03-15 | 1992-01-02 | Menschlicher rezeptor für das follikel- stimulierendes hormon. |
AT01202809T ATE505486T1 (de) | 1991-03-15 | 1992-01-02 | Rezeptor für das menschliche follikel- stimulierende hormon |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01202809T ATE505486T1 (de) | 1991-03-15 | 1992-01-02 | Rezeptor für das menschliche follikel- stimulierende hormon |
Country Status (19)
Country | Link |
---|---|
US (3) | US6121016A (de) |
EP (2) | EP0575357B1 (de) |
JP (1) | JP3581148B2 (de) |
KR (1) | KR100245250B1 (de) |
AT (2) | ATE224446T1 (de) |
AU (1) | AU671417B2 (de) |
CA (1) | CA2106061C (de) |
DE (2) | DE69232779T2 (de) |
DK (1) | DK0575357T3 (de) |
ES (1) | ES2183806T3 (de) |
FI (1) | FI109360B (de) |
GE (1) | GEP19991604B (de) |
LT (1) | LT3973B (de) |
LV (1) | LV10724B (de) |
MX (1) | MX9203350A (de) |
NO (1) | NO315517B1 (de) |
RU (1) | RU2193599C2 (de) |
UA (1) | UA43826C2 (de) |
WO (1) | WO1992016620A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3949893A (en) * | 1992-03-30 | 1993-11-08 | Akzo Nobel N.V. | Human gonadotropin receptor (FSH receptor) |
EP1557432B1 (de) | 1996-02-20 | 2013-08-21 | Merck Serono SA | Heterodimerebildende Hybrid-Proteine |
CA2250975A1 (en) * | 1996-04-15 | 1997-10-23 | The Board Of Trustees Of The Leland Stanford Junior University | Soluble 7-transmembrane domain g-protein-coupled receptor compositions and methods |
US6521641B1 (en) * | 1998-10-08 | 2003-02-18 | Allergan, Inc. | Male anti-fertility agents |
US7273932B1 (en) | 1999-05-28 | 2007-09-25 | The University Of Cincinnati | Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use |
EP1287135A2 (de) * | 2000-05-18 | 2003-03-05 | Bayer Aktiengesellschaft | Regulation eines menschlichen, follikel-stimulierenden hormon-ähnlichen g-protein gekoppelten rezeptors |
US20030175889A1 (en) * | 2002-01-23 | 2003-09-18 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated versions of human G protein coupled receptor: FSHR |
EP1466620A1 (de) * | 2003-04-11 | 2004-10-13 | AXXAM S.r.l. | Modulatoren des Follikel-stimulierenden Hormon-Rezeptors und ihre therapeutische Verwendung |
US20100061976A1 (en) * | 2008-07-24 | 2010-03-11 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4652450A (en) | 1984-08-31 | 1987-03-24 | Research Corporation | Bacterial FSH binding inhibitor |
US4761371A (en) | 1985-02-12 | 1988-08-02 | Genentech, Inc. | Insulin receptor |
US4859609A (en) * | 1986-04-30 | 1989-08-22 | Genentech, Inc. | Novel receptors for efficient determination of ligands and their antagonists or agonists |
US4921808A (en) * | 1986-06-25 | 1990-05-01 | The Albany Medical College Of Union University | Method for determining follicle stimulating hormone |
US4960700A (en) * | 1986-12-24 | 1990-10-02 | Genentech, Inc. | Compositions and methods for the synthesis and assay of a mammalian enkephalinase |
ES2068388T3 (es) * | 1989-05-05 | 1995-04-16 | Genentech Inc | Moleculas de receptor de hormona de la glucoproteina. |
US5155218A (en) * | 1990-05-08 | 1992-10-13 | Neurogenetic Corporation | Dna encoding human 5-ht1d receptors |
-
1992
- 1992-01-02 JP JP50530292A patent/JP3581148B2/ja not_active Expired - Lifetime
- 1992-01-02 AT AT92904833T patent/ATE224446T1/de not_active IP Right Cessation
- 1992-01-02 AT AT01202809T patent/ATE505486T1/de not_active IP Right Cessation
- 1992-01-02 ES ES92904833T patent/ES2183806T3/es not_active Expired - Lifetime
- 1992-01-02 DE DE69232779T patent/DE69232779T2/de not_active Expired - Lifetime
- 1992-01-02 DK DK92904833T patent/DK0575357T3/da active
- 1992-01-02 RU RU93057956/13A patent/RU2193599C2/ru active
- 1992-01-02 DE DE69233805T patent/DE69233805D1/de not_active Expired - Lifetime
- 1992-01-02 WO PCT/US1992/000122 patent/WO1992016620A1/en active IP Right Grant
- 1992-01-02 EP EP92904833A patent/EP0575357B1/de not_active Expired - Lifetime
- 1992-01-02 EP EP01202809A patent/EP1167385B1/de not_active Expired - Lifetime
- 1992-01-02 AU AU12514/92A patent/AU671417B2/en not_active Expired
- 1992-01-02 CA CA002106061A patent/CA2106061C/en not_active Expired - Lifetime
- 1992-01-02 GE GEAP19921579A patent/GEP19991604B/en unknown
- 1992-02-01 UA UA93004376A patent/UA43826C2/uk unknown
- 1992-06-25 MX MX9203350A patent/MX9203350A/es unknown
-
1993
- 1993-09-14 NO NO19933272A patent/NO315517B1/no not_active IP Right Cessation
- 1993-09-14 FI FI934023A patent/FI109360B/fi active
- 1993-09-15 KR KR1019930702771A patent/KR100245250B1/ko not_active IP Right Cessation
- 1993-10-11 LV LVP-93-1136A patent/LV10724B/en unknown
- 1993-12-20 LT LTIP1631A patent/LT3973B/lt not_active IP Right Cessation
-
1995
- 1995-06-07 US US08/482,855 patent/US6121016A/en not_active Expired - Lifetime
- 1995-06-07 US US08/487,886 patent/US5744448A/en not_active Expired - Lifetime
- 1995-06-07 US US08/474,986 patent/US6372711B1/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8603966D0 (sv) | Fluoroaluminosilicate glass powder for dental glass ionomer cement | |
ATE464067T1 (de) | Bindegewebs wachstumsfaktor (ctgf) | |
DK0440777T3 (da) | Neurotrofisk faktor stammende fra hjernen | |
DE10075011I2 (de) | Rezeptoren für Tumornekrosisfaktor-alpha und-beta. | |
DE69233805D1 (de) | Rezeptor für das menschliche Follikel-stimulierende Hormon | |
HUT57827A (en) | Recombinant protein receptor and process for producing same | |
KR980002066A (ko) | 변이형 인간 성장호르몬 및 그의 용도 | |
EP0562123A4 (de) | ||
ATE115409T1 (de) | Glykoprotein-hormonrezeptor-moleküle. | |
ATE142256T1 (de) | Polypeptid und dessen herstellung | |
RU93057956A (ru) | Рецептор, днк, вектор, клетка, способ получения рецептора, фармацевтическая композиция, способы анализа, способ снижения биоактивности, способы предупреждения спермадогенеза и созревания фолликулов | |
FI950883A (fi) | BAPP-C100-reseptorin kloonaus ja ilmentäminen | |
WO2003052377A9 (en) | 41 human secreted proteins | |
ATE124722T1 (de) | Für das plazentaprotein 9 (pp9) kodierende cdna, ihre isolierung und verwendung. | |
ATE357520T1 (de) | Biologisches material zur behandlung eines säugetieres durch transfer einesfür einen antikörper kodierendes gen und eine pharmazeutische zusammensetzungdie diese enthält | |
IT1254705B (it) | Anticorpi monoclonali specifici per il fattore neuronotrofico ciliare (cntf) umano ricombinante |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EEFA | Change of the company name | ||
EELA | Cancelled due to lapse of time |